Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 11, 2022.
Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
The NeurologyLive® October issue's editor-in-chief, Mary Rensel, MD, writes that acting as an advocate is meaningful to neurologists because it speaks to their inner core—or their “why.” Neurologists have the agency to make this world a better place while working as a neurologist and an advocate at many levels.
Chaired by Robert T. Naismith, MD, of Washington University in St. Louis, the presentations on mulitple sclerosis also feature Salim Chahin, MD, MSCE; Anne H. Cross, MD; Gregory F. Wu, MD, PhD; and Matthew R. Brier, MD, PhD.
In the latest edition of our in-depth Q&A series, the adult neurologist at Allegheny Health Network provided perspective on why there has never been a better time to treat patients with myasthenia gravis.
In the NeurologyLive® October issue, Parneet Grewal, MBBS, and Anindita Deb, MD, write about the Palatucci Advocacy Leadership Forum, or PALF, sponsored by the American Academy of Neurology, and how it gives neurologists and trainees tools to successfully advocate for their ideas and develop their identity as physician advocates.
Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP, and Debra Davis, CRN, provide an overview of the prevalence of insomnia in clinical practice, in this NeurologyLive® Peers & Perspectives series, called, "Advanced Practice Providers’ Perspectives on Sleep Disorders: Impact of Insomnia on Patient Health".